Molecular epidemiologic comparison of 2 unusual clusters of group A streptococcal necrotizing fasciitis in Hawaii

Clinical Infectious Diseases

Volumn 40, Issue 12, 2005, Pages 1851-1854

  Erdem, Guliz ^a   Ford, Jacqueline M ^a   Kanenaka, Rebecca Y ^b   Abe, Lucienne ^a   Yamaga, Karen ^a   Effler, Paul V ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b HAWAII STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ISOLATE; CLUSTER ANALYSIS; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; NECROTIZING FASCIITIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS GROUP A; UNITED STATES;

ADULT; AGED; BACTEREMIA; BACTERIAL PROTEINS; CELLULITIS; EPIDEMIOLOGY, MOLECULAR; FASCIITIS, NECROTIZING; FEMALE; HAWAII; HUMANS; MALE; RISK FACTORS; STREPTOCOCCUS PYOGENES;

EID: 20444377783     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430378     Document Type: Article

References (15)

1. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997; 103:18-24.
2. O'Brien K, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35:268-76.
3. Sharkawy A, Low DE, Saginur R, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
4. Stevens DL. Invasive streptococcal infections. J Infect Chemother 2001; 7:69-80.
5. File TM. Necrotizing soft tissue infections. Curr Infect Dis Rep 2003; 5:407-15.
6. Fraser CA, Ball LC, Morris CA, Noah ND. Serological characterization of group-A streptococci associated with skin sepsis in meat handlers. J Hyg (Lond) 1977; 78:283-96.
7. Nekomoto TS, Manea SJ, Kanenaka RY, Burr RK, Effler PV. Characterization of group A streptococci isolates from hospitalized case patients and asymptomatic school children, Kauai, Hawaii, 1997. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). San Francisco: American Society for Microbiology, 1999:657.
8. Erdem G, Abe L, Kanenaka, RY, et al. Characterization of a community cluster of group A streptococcal invasive disease in Maui, Hawaii. Pediatr Infect Dis J 2004; 23:677-9.
9. Centers for Disease Control and Prevention. Streptococcus pyogenes emm sequence database. Available at: http://www.cdc.gov/ncidod/biotech/strep/ strepindex.htm. Accessed 28 April 2005.
10. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953-8.
11. DiPersio JR, File TM, Stevens DL, Gardner WG, Petropoulos G, Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis 1996; 22:490-5.
12. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002; 70:2171-7.
13. Factor SH. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003; 9:970-7.
14. Schwartz B, Facklam R, Breiman R. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-71.
15. Kaplan EL, Wotton JT, Johnson DR. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet 2001; 358:1334-7.